Fermenta Biotech Limited

FERMENTA

INE225B01021

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:57 2024-06-28 EDT			5-day change	1st Jan Change
166 ^INR	-0.12%		-1.37%	+2.72%

05-27	Fermenta Biotech Limited Announces Company Secretary Changes	CI
05-27	Fermenta Biotech Limited Proposes Dividend for the Financial Year Ended March 31, 2024, Payable on or Before August 22, 2024	CI

Fermenta Biotech Limited Appoints Rajashri Santosh Kumar Ojha as an Additional (Independent) Director

April 02, 2020 at 12:46 am

Fermenta Biotech Limited announced the appointment of Ms. Rajashri Santosh Kumar Ojha as an Additional (Independent) Director on the Board of Directors of the Company with effect from April 1, 2020.

Latest news about Fermenta Biotech Limited

Fermenta Biotech Limited Announces Company Secretary Changes	05-27	CI
Fermenta Biotech Limited Proposes Dividend for the Financial Year Ended March 31, 2024, Payable on or Before August 22, 2024	05-27	CI
Fermenta Biotech Limited Announces the Retirement of Gopakumar Nair as Independent Director	05-16	CI
Fermenta Biotech Sells Premises in Thane, India for INR136 Million	02-15	MT
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Fermenta Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Fermenta Biotech Sells Land in Pune, India for INR448 Million	12-05	MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB; Outlook Negative	11-16	MT
Fermenta Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
Fermenta Biotech Limited Approves Dividend for the Financial Year Ended March 31, 2023, Payable on or Before October 10, 2023	23-09-29	CI
Fermenta Biotech Opens Premix Plant in Kullu, India	23-09-07	MT
Fermenta Biotech Limited Announces Inauguration of Customized Premix Manufacturing Plant in Kullu, Himachal Pradesh	23-09-07	CI
Fermenta Biotech Resumes Full Operations of Kullu Plant in Himachal Pradesh, India	23-08-13	MT
Fermenta Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Fermenta Biotech Resumes Partial Operations at Himachal Pradesh, India Facility	23-07-23	MT
Fermenta Biotech Halts Operations at Himachal Pradesh, India Facility Due to Heavy Rain	23-07-11	MT
Fermenta Biotech Limited Announces Suspension of Operations Due to Heavy Rainfall in Himachal Pradesh	23-07-11	CI
Fermenta Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29	CI
Fermenta Biotech Limited Recommends Final Equity Dividend for the Financial Year Ended March 31, 2023	23-05-29	CI
Fermenta Biotech Sells Premises in Thane, India for INR66 Million	23-05-25	MT
Fermenta Biotech Sells Property in Maharashtra, India for INR140.5 Million	23-05-17	MT
Fermenta Biotech Sells Company Premises in Thane, India for INR140 Million	23-05-16	MT
CARE Cuts Rating on Fermenta Biotech's Long-term Bank Financing to BBB+; Revises Outlook to Negative	23-04-07	MT
Fermenta Biotech Signs Pact to Sell Premises in Thane, India for INR140 Million	23-03-30	MT
Fermenta Biotech Sells Property in Maharashtra, India for INR 116 Million	23-03-21	MT

Chart Fermenta Biotech Limited

Duration

Period

More charts

Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. The Company's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The Company has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The Company provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.

Sector

Pharmaceuticals

Calendar

2024-08-05 - Détachement de for final dividend

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
FERMENTA BIOTECH LIMITED	+2.72%	57.5M
CSL LIMITED	+2.99%	95.18B
SAMSUNG BIOLOGICS CO.,LTD.	-4.34%	37.55B
UCB	+75.79%	28.2B
BIOMARIN PHARMACEUTICAL INC.	-14.61%	15.63B
INCYTE CORPORATION	-3.46%	13.63B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.31%	11.5B
ALTEOGEN INC.	+184.77%	10.81B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54.13%	9.23B
SWEDISH ORPHAN BIOVITRUM AB	+6.22%	9.09B

Biopharmaceuticals